(2R,3R)-Hydroxybupropion
Metabolite of bupropion

(2R,3R)-Hydroxybupropion is a pharmacologically active metabolite of the antidepressant and smoking cessation aid bupropion. It is one of the major metabolites formed during the metabolism of bupropion in the human body.
Chemical Structure and Properties[edit]
(2R,3R)-Hydroxybupropion is a chiral compound, meaning it has a specific three-dimensional arrangement of atoms that is not superimposable on its mirror image. The chemical structure of (2R,3R)-Hydroxybupropion includes a hydroxyl group attached to the bupropion molecule, which significantly influences its pharmacological activity.
Pharmacology[edit]
(2R,3R)-Hydroxybupropion is known to contribute to the therapeutic effects of bupropion. It acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), similar to its parent compound. This action increases the levels of the neurotransmitters norepinephrine and dopamine in the brain, which are associated with mood regulation and reward pathways.
Metabolism[edit]
Bupropion is metabolized in the liver primarily by the enzyme cytochrome P450 2B6 (CYP2B6) to form (2R,3R)-Hydroxybupropion. This metabolite is present in higher concentrations in the plasma than bupropion itself, indicating its significant role in the drug's overall pharmacological profile.
Clinical Significance[edit]
The presence of (2R,3R)-Hydroxybupropion is important for the clinical efficacy of bupropion. It is believed to contribute to both the antidepressant and smoking cessation effects of the drug. The metabolite's activity as an NDRI supports the therapeutic outcomes observed in patients using bupropion for these indications.
Safety and Side Effects[edit]
While (2R,3R)-Hydroxybupropion contributes to the therapeutic effects of bupropion, it may also be involved in some of the side effects associated with the parent drug. Common side effects of bupropion include insomnia, dry mouth, and dizziness, which may be partly attributed to the action of its metabolites.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian